CRNX - Crinetics Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$84.86
DETAILS
HIGH:
$85.00
LOW:
$84.00
MEDIAN:
$85.00
CONSENSUS:
$84.86
DOWNSIDE:
0.11%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 46,381 | $1.7M | 0.0% | +46,381 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-01 | Fust Matthew K | director | D-Return | 12,500 | $44.71 | $559K |
| 2026-09-01 | Fust Matthew K | director | D-Return | 17,500 | $20.32 | $356K |
| 2026-09-01 | Schilke Tobin | officer: Chief Financial & Infra. Ofcr. | D-Return | 80,000 | $33.75 | $2.7M |
| 2026-09-01 | Deardorf Caren | director | D-Return | 10,350 | $32.33 | $335K |
| 2026-09-01 | Schilke Tobin | officer: Chief Financial & Infra. Ofcr. | D-Return | 71,471 | $85.00 | $6.1M |
| 2026-09-01 | Struthers Richard Scott | director, officer: President & CEO | D-Return | 176,663 | $85.00 | $15.0M |
| 2026-09-01 | Nichols Weston | director | D-Return | 17,500 | $20.32 | $356K |
| 2026-09-01 | Fust Matthew K | director | D-Return | 5,925 | $85.00 | $504K |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 60,000 | $22.61 | $1.4M |
| 2026-09-01 | Bedrosian Camille L | director | D-Return | 17,500 | $20.32 | $356K |
| 2026-09-01 | Vivaldi Coelho Rogerio | director | D-Return | 17,500 | $20.32 | $356K |
| 2026-09-01 | Okey Stephanie | director | D-Return | 10,350 | $32.33 | $335K |
| 2026-09-01 | Okey Stephanie | director | D-Return | 9,730 | $35.87 | $349K |
| 2026-09-01 | Nichols Weston | director | D-Return | 12,500 | $44.71 | $559K |
| 2026-09-01 | Nichols Weston | director | D-Return | 10,350 | $32.33 | $335K |
| 2026-09-01 | Deardorf Caren | director | D-Return | 4,375 | $18.29 | $80K |
| 2026-09-01 | Deardorf Caren | director | D-Return | 17,500 | $20.32 | $356K |
| 2026-09-01 | Deardorf Caren | director | D-Return | 12,500 | $44.71 | $559K |
| 2026-09-01 | Bedrosian Camille L | director | D-Return | 25,000 | $16.08 | $402K |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 85,000 | $15.29 | $1.3M |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 15,000 | $23.19 | $348K |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 87,000 | $43.51 | $3.8M |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 65,000 | $36.86 | $2.4M |
| 2026-09-01 | Betz Stephen F. | officer: Chief Scientific Officer | D-Return | 47,000 | $43.79 | $2.1M |
| 2026-09-01 | Schilke Tobin | officer: Chief Financial & Infra. Ofcr. | D-Return | 7,956 | $85.00 | $676K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-09-07 | Gilbert Cisneros | HOUSE | Sale | $15,001 - $50,000 |
| 2026-09-07 | Gilbert Ray Cisneros | HOUSE | Sale (Full) | $15,001 - $50,000 |